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Purpose or Objective: o evaluate an automatic registration 
of partial cone beam CT scan’s and full cone beam CT scan’s 
position errors, durations and doses for Breast Cancer 
 
Material and Methods: Before the IMRT treatment’s of breast 
cancer patients using Versa HD, five breast cancer patients 
were scanned in the same position with partial cone beam CT 
and a full cone beam CT in sequence. The patient position 
errors were determined using automatic registration methods 
in both cases. The full cone beam CT parameters 
corresponded to the default VolumeView “Chest M20” preset 
in XVI 4.5; 360 degree, 180 deg/min velocity, 120 kV, 660 
frames, 1056mAs and nominal scan dose of 22mGy. Partial 
cone beam CT parameters were set by us, we choosed S20 
filter instead of M20 filter and for right breast; gantry angle 
was CW direction from 180° to 10°, for left breast; gantry 
angle was CW direction from 300° to 130°, 180deg/min 
velocity, 100 kV, 366 frames, 585.6mAs. Both cone beam CT 
scans were performed in sequence for five patients and 
position errors in 3 diemensions recorded using automatic 
registration method with for rotational bone value 
registration, gray value registration and rotational gray value 
registration. 
 
Results: We compared partial cone beam CT scan’s position 
errors with full cone beam CT scan’s position errors. Firstly, 
we found an average difference of 1,46mm in lateral 
direction, 1.80mm in longitudinal direction and 1.96mm in 
vertical direction difference for bone value rotational 
automatic registration. Secondly, we determined an average 
1,24mm in lateral direction, 1,36mm in longitudinal 
direction, 1,30mm in vertical direction difference for gray 
value rotational automatic registration. Thirdly, we 
determined an average 1,56mm in lateral direction, 1,88mm 
in longitudinal direction, 1,52mm in vertical direction 
difference for gray value automatic registration.  
 
Conclusion: Most probably these differences are resulting 
from time difference between two cone beam CT scans and 
also it could be related with patient’s breathing phase during 
scanning. Altough the partial cone beam CT scan’s image 
quality were worde than with full cone beam CT scan the 
automatic registration parameter’s difference were below 
2,0mm in 3 dimensions. When we measured radiation at the 
isocentre point using cylindrical ion chamber wih 30 cm x 30 
cm solid phantom for both cone beam CT tecniques, radiation 
dose decreased % 55±5 with partial cone beam CT scan. 
Additionally, Cone beam CT scan’s duration decreased %40 
with partial cone beam CT scan. 
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Purpose or Objective: Secondary cancer induction is a 
severe effect of Radiation Therapy (RT) treatments. 
Volumetric Arc Therapy (VMAT) techniques delivery dose 
distribution with a significant area and organs involved of low 
dose. We have evaluated, from the dosimetric data of 
patients treated using VMAT practice, the risk for 
contralateral breast and lung secondary tumor, estimating 
the Organ Equivalent Dose (OED). 
 
Material and Methods: 30 patients, treated with VMAT 
techniques for breast cancer, were analyzed using the dose 
distribution. Based on the anatomical side of treatment (right 
and left side), the cohort was divided in two groups of 
treatment. We have calculated the OED of ipsilateral and 
contralateral organs, relatively to the breast and lung 
tissues. Using the bell shaped model formula, we obtained 
the OED from the dose volume histogram (DVH) of each 
organ. Using a MATLAB® toolbox (DVH analyzer), the 
estimation of the OED values for contralateral and ipsilateral 
organ was assessed. 
 
Results: The results, summarized in Figure1 and Table1, 
showed a mean ODE of +2,09±0,32Gy for contralateral lung, 
+1,94±0,32Gy for ipsilateral lung and +2,55±0,61Gy for 
contralateral breast. An ANOVA analysis showed that the side 
of treatment (left or right) was irrelevant for OED estimation 
(sign.≈1), confirming the independence by the VMAT 
techniques applied. The study confirmed that contralateral 
organs are the major tissue involved in risk of the secondary 
cancer risk, in particular for the contralateral breast. The 
OED showed, per patients’ treated group, a variability of 
[2,1÷3,1] Gy for the right side and [2,2÷3,8] Gy for the left 
side. The OED for lung and contralateral lung had less 
variability in case of treatment. According with the radio 
sensitivity of the breast tissue, a special attention should be 
applied during the optimization and treatment to avoid 
possible variability in inducted cancer risks. 
 
 
 
 
Conclusion: The ODE data and bell shaped model, obtained 
from the DVH curves, can be used for the prediction of 
radiation secondary cancer induction. The OED values 
obtained showed the low risk of secondary cancer induction 
of the VMAT techniques compared with other literature data. 
Most uncertainties still remain related the time patterns of 
cancer induction and the specific dependencies to the organs 
rates. For RT plan optimization these factors are irrelevant; 
therefore, to endorse the safety distribution obtained by 
VMAT techniques, mathematical models obtained by the DVH 
and OED should be investigated with epidemiological absolute 
risk data of large patients’ database.  
 
EP-1617  
Pre-treatment and in vivo fetal dosimetry in brain 
radiotherapy treatment during pregnancy 
M. Valenti
1Azienda Ospedaliero Universitaria Ospedali Riuniti, Medical 
Physics, Ancona, Italy 
1, M. Parisotto1, C. Ardito1, M. Puschi1, S. 
Costantini2, M. Cardinali2, S. Maggi1 
2Azienda Ospedaliero Universitaria Ospedali Riuniti, 
Radiotherapy, Ancona, Italy 
ESTRO 35 2016                                                                                                                                                    S753 
________________________________________________________________________________ 
Purpose or Objective: Radiotherapy treatment of pregnant 
women is a relevant problem in term of fetus 
radioprotection. A preliminary dosimetric evaluation of fetal 
dose could influence clinical decision of patient irradiation 
and, once the treatment has been approved, an accurate 
dose evaluation is important to estimate fetal radiation 
exposure risks. Fetal dose irradiation risks are described in 
AAPM report n.50 [1] and ICRP 84 [2] where is proposed a 
fetal dose limit of 10 cGy. In this work we describe 
dosimetric measurements related to a brain treatment for a 
pregnant woman in term of: preliminary measurements for 
optimal plan parameters assessment, pre-treatment in 
phantom dose measurements of approved plan and in vivo 
dosimetry to confirm pre-treatment evaluation. 
 
Material and Methods: Treatment has been performed with 
3DCRT on a Clinac 21 EX with dose of 60Gy in 30 sessions. At 
the time of dose evaluation patient was in 22° week of 
pregnancy. Distance from umbilicus to lower field edge is 
53cm. Preliminary and pre-treatment measurements have 
been performed with both farmer ionization chamber in 
Rando phantom modified adding a water phantom and with 
TLD 100 in Rando phantom with bolus. Use of bolus over 
Rando phantom reproduces in a better way patient shape and 
dimension. During all treatment we perform daily in vivo TLD 
dosimetry. In preliminary measurement session we evaluate 
relation between fetal dose and: field dimension, collimator 
rotation, presence of MLC, use of enhanced dynamic wedge 
(EDW) and thickness of lead shielding. We also study change 
of dose with distance from radiation field edge and with 
measurement depth.  
 
Results: About treatment parameters we observed an 
important dose reduction using 90° collimator rotation and 
using MLC [4]. Fetal dose increase with EDW is acceptable 
only for small angles. The more relevant parameters related 
to dose increase are distance from field edge and field 
dimension. These are anatomy related parameters and 
cannot be optimized. Considering measured value of fetal 
unshielded dose (in the range of 1-2 cGy) we decide to use 
8mm thickness lead shielding [3]. In preliminary phase we 
observed a little increase in dose with depth as reported in 
[5]. Result of pre-treatment and in vivo measurement is 
reported in table 1. 
 
Conclusion: Treatment parameters like collimator rotation, 
MLC or EDW strongly influence fetal dose. This aspect must 
be considered in patient plan preparation. Pre treatment 
dosimetry is important to estimate fetal clinical irradiation 
risk and to evaluate the need and thickness of lead shielding. 
In vivo dosimetry is always important to confirm pre 
treatment dose evaluation. Differences between pre 
treatment and in vivo dosimetry should be attributed to 
differences in patient and phantom shape, dimension and 
internal structure. In our case we can give a precautionary 
estimation of fetal dose of 1.6 cGy, a value below 10cGy 
limit proposed by [1.2] 
[1] Stovall 
[2] ICRP 84  
[3] Haba 
[4] Sharma 
[5] Sneed 
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Purpose or Objective: to calculate organ doses for several 
protocols of a radiotherapy cone beam equipment using the 
PCXMC software, validated comparing doses with TLDs. 
Furthermore a set of coefficients to provide an estimation of 
organ doses was assessed for patients of different genders 
and sizes. 
 
Material and Methods: The system in use was an Elekta CBCT 
(XVI) and the protocols analysed were four: head, pelvis, 
chest and chest4D with different parameters. The first part 
of the study investigated the opportunity to use PCXMC, a 
software based on Montecarlo simulation generally employed 
for projective radiology, for calculating organ doses. This 
commercial software allows the user to specify patient age 
and size, radiation beam geometrical setup, beam energy, 
filtration; a dosimetric indicator (entrance skin dose or DAP) 
is required to calculate final organ and effective doses. A 
new version of the software introduces the possibility to 
simulate rotational beams, subdividing the exposure in single 
contributions at different angles and performing the total 
doses calculation in a batch way. The software was adapted 
to better simulate the modulated filtration of this particular 
CBCT considering different filtered beam contributions. A set 
of 50 TLDs (Harshaw – TLD 100) was selected, irradiated and 
analysed, for each protocol, to compare measurements with 
PCXMC results. The influence of patient size on organ dose 
was evaluated varying heights, weights and genders. Three 
levels of height and weight corresponding respectively to the 
5th, 50th and 95th percentile of US males and females adult 
population were considered. The organ doses were 
normalized to the PCXMC standard adult phantom doses and 
the calculated ratios were plotted versus the equivalent 
diameter of each patient size. 
 
Results: The differences between PCXMC and TLDs doses are 
shown in table I for different protocols;  
 
 
 
The respiratory airways and the prostate show a difference 
over 15%, probably as a consequence of their position at the 
boundaries of the beam, with a critical match of exposure 
geometry for actual and virtual anthropomorphic phantoms. 
Regarding simulations with patients of different heights, 
weights and genders a variability in a range ±40% for pelvic 
region and ±30% for chest was observed; specifically, for the 
same acquisition protocol, organ doses for a slim patient 
could be much higher than the organ dose of an overweight 
patient. Fig 1 shows, as an example, dose correction factors 
versus equivalent diameters for breast with different 
protocols and relative fits.  
 
Fig 1 correction factor vs patient equivalent diameter 
